MS Canada is hosting its annual MS Read-a-Thon, a fundraiser encouraging children to turn their reading goals into donations to support people with multiple sclerosis (MS). This year’s event aims to raise CA$65,000 (nearly $48,000) to support MS research and community programs. So far, 565 people have registered, and…
Discussion
When I was diagnosed with relapsing-remitting multiple sclerosis (MS) at 16, it was loud. My symptoms were significant; the fatigue ended my athletic drive, the searing nerve pain left me grinding my teeth constantly, and I experienced a period of being legally blind. MS didn’t politely…
Following specific diets may help reduce inflammation in people with multiple sclerosis (MS), but more research is needed, according to a new review paper. Researchers analyzed data from 13 randomized clinical trials and found some evidence that certain diets, including modified Mediterranean-style and Paleolithic diets, were linked to…
A type of immune cell that has received little attention in multiple sclerosis (MS) research may play a key role in driving the disease. A study found that some people with MS had abnormally high levels of virus-fighting CD8 T-cells in the fluid surrounding the brain and spinal cord.
A clinical trial testing TG Therapeutics‘ CD20 inhibitor Briumvi (ublituximab-xiiy) in children with relapsing forms of multiple sclerosis (MS) will begin enrolling participants within the next few months, the developer announced, also unveiling details of the study’s design. The upcoming Phase 2/3 trial (NCT07220252) will run…
Get regular updates to your inbox.
